Security key
682310875
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)
CUSIP: 682310875
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, no par value
- Total 13F shares
- 1,309,286
- Total 13F value
- $1,297,302
- Share change
- -115,021
- SEC-reported price per share
- $0.99
- Number of holders
- 41
- Value change
- -$118,709
- Number of buys
- 15
- Number of sells
- 13
- Shares outstanding
- 109,272,143
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
41
Top holders
10
ONCY full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
ONCOLYTICS BIOTECH INC SEC filings
ONCOLYTICS BIOTECH INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 682310875
Recent filing periods:
Ownership snapshot
Top reported holders of ONCY - ONCOLYTICS BIOTECH INC - Common Stock, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 0.32%
Showing 1-6 of 15 holder rows.
Quick read
MORGAN STANLEY leads the comparable SEC ownership view at 0.32%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MORGAN STANLEY's linked filing trail.
Comparable ownership
Top 5
MORGAN STANLEY
0.32%
INTERNATIONAL ASSETS INVESTMENT M...
0.18%
CITADEL ADVISORS LLC
0.15%
GOLDMAN SACHS GROUP INC
0.08%
COMMONWEALTH EQUITY SERVICES, LLC
0.06%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
Company
|
0.32%
|
$369,212
348,313 shares
|
— | 31 Mar 2024 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC |
13F
Company
|
0.18%
|
$213,539
201,452 shares
|
— | 31 Mar 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.15%
|
$172,531
162,765 shares
|
— | 31 Mar 2024 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
0.08%
|
$88,614
83,598 shares
|
— | 31 Mar 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
Company
|
0.06%
|
$67,000
62,764 shares
|
— | 31 Mar 2024 |
| ROYAL BANK OF CANADA |
13F
Company
|
0.06%
|
$65,000
61,033 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
41
Shares
1,309,286
Rows available
41
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
35
Q2 2024 holders
41
Holder diff
6
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend